Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
11 hedge funds and large institutions have $59.2K invested in Petros Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 11 → 11 (0)
0.05% less ownership
Funds ownership: 0.12% → 0.07% (-0.05%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
38% less capital invested
Capital invested by funds: $94.9K → $59.2K (-$35.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$16.6K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.68K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$75 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$32K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$8.1K |
| 3 |
BlackRock
New York
|
-$141 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9 |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $15.8K | +$16.6K | +1,769 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $13.4K | +$2.68K | +286 | +24% |
|
|
TSS
3
Two Sigma Securities
New York
| $11.5K | -$8.1K | -864 | -40% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $11.4K | – | – | – |
|
|
5
BlackRock
New York
| $5.76K | -$141 | -15 | -2% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1.16K | -$9 | -1 | -0.8% |
|
7
National Bank of Canada
Montreal,
Quebec, Canada
| $112 | – | – | – |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $72 | +$75 | +8 | New |
|
9
Group One Trading
Chicago,
Illinois
| $28 | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $26 | +$9 | +1 | +50% |
|
11
Morgan Stanley
New York
| $7 | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$32K | -2,810 | Closed |
|
|
13
1832 Asset Management
Toronto,
Ontario, Canada
| – | -$5 | – | – |
|
PTPI Hedge Fund Activity: Q3 2024 in Review
11 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q3 2024, worth a combined $59.2K — down 38% from $94.9K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PTPI positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $16.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $32K sold.
- 11 institutional investors held Petros Pharmaceuticals (PTPI) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $59.2K of Petros Pharmaceuticals stock for Q3 2024, down 38% quarter-over-quarter.
- 2 funds opened new Petros Pharmaceuticals positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest Petros Pharmaceuticals buyer in Q3 2024 was UBS Group, an estimated $16.6K added.
- The largest Petros Pharmaceuticals seller in Q3 2024 was Virtu Financial, an estimated $32K sold.
Based on aggregated 13F filings for Q3 2024.